Concepts (407)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carotenoids | 39 | 2025 | 79 | 11.360 |
Why?
|
| Bees | 24 | 2024 | 52 | 9.010 |
Why?
|
| Symbiosis | 26 | 2024 | 103 | 7.380 |
Why?
|
| Diet | 21 | 2025 | 1125 | 3.960 |
Why?
|
| Gastrointestinal Microbiome | 14 | 2024 | 810 | 3.210 |
Why?
|
| Hemiptera | 8 | 2022 | 18 | 2.760 |
Why?
|
| Vegetables | 10 | 2025 | 273 | 2.680 |
Why?
|
| Gammaproteobacteria | 7 | 2022 | 22 | 2.680 |
Why?
|
| Bacteria | 17 | 2025 | 522 | 2.610 |
Why?
|
| Gastrointestinal Tract | 13 | 2017 | 232 | 2.470 |
Why?
|
| Aphids | 7 | 2023 | 14 | 2.350 |
Why?
|
| Fruit | 13 | 2025 | 234 | 2.290 |
Why?
|
| Buchnera | 6 | 2021 | 6 | 2.080 |
Why?
|
| Genome, Bacterial | 10 | 2025 | 213 | 2.040 |
Why?
|
| beta Carotene | 6 | 2024 | 34 | 2.010 |
Why?
|
| Skin | 5 | 2024 | 527 | 1.780 |
Why?
|
| Phylogeny | 13 | 2025 | 763 | 1.700 |
Why?
|
| Neisseriaceae | 4 | 2020 | 5 | 1.650 |
Why?
|
| Prostatic Neoplasms | 9 | 2024 | 1576 | 1.600 |
Why?
|
| Type VI Secretion Systems | 2 | 2024 | 3 | 1.460 |
Why?
|
| Milk, Human | 3 | 2024 | 308 | 1.450 |
Why?
|
| Intestinal Absorption | 3 | 2017 | 176 | 1.440 |
Why?
|
| Spectrum Analysis | 5 | 2024 | 66 | 1.340 |
Why?
|
| Animals | 61 | 2025 | 34782 | 1.330 |
Why?
|
| Vitamin A | 4 | 2025 | 56 | 1.330 |
Why?
|
| Evolution, Molecular | 8 | 2025 | 700 | 1.300 |
Why?
|
| Insecta | 3 | 2015 | 64 | 1.230 |
Why?
|
| Biomarkers | 7 | 2024 | 3405 | 1.020 |
Why?
|
| Dioxygenases | 3 | 2022 | 68 | 0.950 |
Why?
|
| Anticarcinogenic Agents | 3 | 2022 | 48 | 0.900 |
Why?
|
| Nutritional Requirements | 1 | 2025 | 160 | 0.890 |
Why?
|
| beta-Carotene 15,15'-Monooxygenase | 4 | 2024 | 4 | 0.890 |
Why?
|
| Milk | 1 | 2024 | 108 | 0.820 |
Why?
|
| Honey | 1 | 2023 | 4 | 0.820 |
Why?
|
| Nutrition Assessment | 1 | 2024 | 127 | 0.800 |
Why?
|
| Metagenome | 3 | 2014 | 146 | 0.800 |
Why?
|
| Urticaria | 1 | 2023 | 22 | 0.800 |
Why?
|
| Antioxidants | 2 | 2015 | 333 | 0.800 |
Why?
|
| Parasites | 1 | 2023 | 36 | 0.780 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2023 | 31 | 0.780 |
Why?
|
| Soybean Proteins | 2 | 2019 | 16 | 0.760 |
Why?
|
| Microbiota | 6 | 2023 | 434 | 0.750 |
Why?
|
| Host Specificity | 3 | 2017 | 23 | 0.710 |
Why?
|
| Bacterial Physiological Phenomena | 5 | 2018 | 21 | 0.700 |
Why?
|
| Molecular Sequence Data | 12 | 2014 | 3770 | 0.660 |
Why?
|
| Varroidae | 1 | 2020 | 1 | 0.650 |
Why?
|
| Biodiversity | 4 | 2018 | 87 | 0.640 |
Why?
|
| Databases, Factual | 1 | 2024 | 1228 | 0.610 |
Why?
|
| Neonicotinoids | 1 | 2018 | 2 | 0.580 |
Why?
|
| Nitro Compounds | 1 | 2018 | 18 | 0.580 |
Why?
|
| Antibiosis | 1 | 2017 | 14 | 0.560 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2012 | 173 | 0.530 |
Why?
|
| Vitamins | 1 | 2017 | 112 | 0.520 |
Why?
|
| Biological Evolution | 4 | 2022 | 243 | 0.520 |
Why?
|
| Enterobacteriaceae | 2 | 2014 | 41 | 0.520 |
Why?
|
| Bacterial Toxins | 1 | 2017 | 176 | 0.510 |
Why?
|
| Biological Availability | 5 | 2018 | 142 | 0.500 |
Why?
|
| Dietary Fats | 1 | 2017 | 279 | 0.480 |
Why?
|
| Male | 35 | 2025 | 64872 | 0.480 |
Why?
|
| DNA, Bacterial | 6 | 2015 | 494 | 0.480 |
Why?
|
| Prostate | 6 | 2024 | 437 | 0.480 |
Why?
|
| RNA, Ribosomal, 16S | 7 | 2023 | 394 | 0.470 |
Why?
|
| Carcinogenesis | 5 | 2023 | 358 | 0.470 |
Why?
|
| Dietary Supplements | 2 | 2015 | 439 | 0.460 |
Why?
|
| Cancer Survivors | 1 | 2018 | 249 | 0.450 |
Why?
|
| Lutein | 3 | 2023 | 14 | 0.450 |
Why?
|
| Health Promotion | 1 | 2018 | 399 | 0.450 |
Why?
|
| Genomics | 4 | 2025 | 1647 | 0.450 |
Why?
|
| Genotype | 4 | 2024 | 2697 | 0.440 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2024 | 2850 | 0.430 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 316 | 0.420 |
Why?
|
| Infant Nutritional Physiological Phenomena | 2 | 2025 | 168 | 0.410 |
Why?
|
| Carbon Isotopes | 5 | 2015 | 233 | 0.410 |
Why?
|
| Sequence Analysis, DNA | 6 | 2014 | 1799 | 0.400 |
Why?
|
| Zeaxanthins | 2 | 2023 | 9 | 0.400 |
Why?
|
| Humans | 41 | 2025 | 131929 | 0.400 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 198 | 0.400 |
Why?
|
| Cross-Sectional Studies | 7 | 2025 | 3760 | 0.390 |
Why?
|
| Tetracycline Resistance | 1 | 2012 | 8 | 0.390 |
Why?
|
| Halomonadaceae | 1 | 2012 | 1 | 0.390 |
Why?
|
| Biota | 1 | 2012 | 8 | 0.390 |
Why?
|
| Infant | 7 | 2025 | 13047 | 0.390 |
Why?
|
| Tetracyclines | 1 | 2012 | 22 | 0.390 |
Why?
|
| RNA 3' End Processing | 1 | 2012 | 7 | 0.380 |
Why?
|
| RNA, Transfer | 1 | 2012 | 69 | 0.370 |
Why?
|
| Models, Biological | 2 | 2015 | 1443 | 0.360 |
Why?
|
| Tissue Distribution | 5 | 2015 | 380 | 0.360 |
Why?
|
| Fabaceae | 2 | 2001 | 21 | 0.350 |
Why?
|
| Isotope Labeling | 4 | 2013 | 92 | 0.350 |
Why?
|
| Amino Acids, Essential | 1 | 2011 | 22 | 0.350 |
Why?
|
| Reproducibility of Results | 4 | 2024 | 3011 | 0.350 |
Why?
|
| Female | 22 | 2025 | 70586 | 0.320 |
Why?
|
| Transcriptome | 1 | 2016 | 1122 | 0.320 |
Why?
|
| Potassium Channels | 2 | 2001 | 160 | 0.320 |
Why?
|
| Self Report | 2 | 2024 | 549 | 0.290 |
Why?
|
| Reproduction | 2 | 2023 | 226 | 0.290 |
Why?
|
| Liver | 5 | 2024 | 1796 | 0.290 |
Why?
|
| Beverages | 2 | 2019 | 101 | 0.290 |
Why?
|
| Glucose | 1 | 2013 | 870 | 0.290 |
Why?
|
| Species Specificity | 4 | 2025 | 541 | 0.280 |
Why?
|
| Adaptation, Biological | 2 | 2020 | 35 | 0.280 |
Why?
|
| Intestines | 1 | 2012 | 604 | 0.280 |
Why?
|
| Genome, Insect | 2 | 2020 | 109 | 0.280 |
Why?
|
| Genetic Variation | 3 | 2025 | 1580 | 0.270 |
Why?
|
| Intracranial Embolism | 2 | 2019 | 27 | 0.260 |
Why?
|
| Middle Aged | 13 | 2024 | 28945 | 0.260 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2017 | 946 | 0.260 |
Why?
|
| Escherichia coli | 3 | 2017 | 995 | 0.250 |
Why?
|
| Gene Expression Regulation | 2 | 2014 | 2437 | 0.250 |
Why?
|
| Fatty Acids | 3 | 2013 | 356 | 0.240 |
Why?
|
| Mutagenesis | 2 | 2017 | 347 | 0.240 |
Why?
|
| Adult | 13 | 2024 | 31538 | 0.240 |
Why?
|
| Carotid Stenosis | 2 | 2019 | 123 | 0.240 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 2645 | 0.240 |
Why?
|
| Recommended Dietary Allowances | 1 | 2025 | 19 | 0.240 |
Why?
|
| Half-Life | 2 | 2015 | 160 | 0.240 |
Why?
|
| Calcium | 2 | 2001 | 1078 | 0.240 |
Why?
|
| Eukaryota | 1 | 2025 | 24 | 0.230 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2024 | 39 | 0.220 |
Why?
|
| Fruit and Vegetable Juices | 1 | 2024 | 5 | 0.220 |
Why?
|
| Diet Records | 1 | 2024 | 71 | 0.220 |
Why?
|
| Parthenogenesis | 1 | 2023 | 3 | 0.210 |
Why?
|
| Alkaloids | 1 | 2024 | 37 | 0.210 |
Why?
|
| Betaproteobacteria | 2 | 2014 | 2 | 0.210 |
Why?
|
| Biofilms | 2 | 2016 | 98 | 0.210 |
Why?
|
| Kinetics | 2 | 2015 | 1129 | 0.210 |
Why?
|
| Cytosol | 2 | 2001 | 144 | 0.210 |
Why?
|
| Nutrition Surveys | 1 | 2025 | 314 | 0.210 |
Why?
|
| Bacteroidetes | 2 | 2014 | 23 | 0.210 |
Why?
|
| Agriculture | 1 | 2023 | 32 | 0.200 |
Why?
|
| Base Sequence | 4 | 2012 | 2899 | 0.200 |
Why?
|
| Genes, Essential | 1 | 2023 | 43 | 0.200 |
Why?
|
| RNA, Double-Stranded | 1 | 2023 | 66 | 0.200 |
Why?
|
| Base Composition | 2 | 2013 | 74 | 0.200 |
Why?
|
| Ecosystem | 2 | 2014 | 107 | 0.200 |
Why?
|
| Ubiquinone | 2 | 2013 | 29 | 0.200 |
Why?
|
| X Chromosome | 1 | 2023 | 340 | 0.190 |
Why?
|
| Bacterial Typing Techniques | 2 | 2013 | 104 | 0.190 |
Why?
|
| Infant Formula | 1 | 2023 | 98 | 0.190 |
Why?
|
| Oxygenases | 1 | 2022 | 4 | 0.190 |
Why?
|
| Polyploidy | 1 | 2022 | 17 | 0.190 |
Why?
|
| Hospitalization | 2 | 2024 | 1898 | 0.190 |
Why?
|
| Organelles | 1 | 2022 | 22 | 0.190 |
Why?
|
| Mice | 9 | 2024 | 18460 | 0.190 |
Why?
|
| Genome | 1 | 2025 | 504 | 0.180 |
Why?
|
| Pulvinus | 1 | 2001 | 1 | 0.180 |
Why?
|
| Work Performance | 1 | 2022 | 14 | 0.180 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2001 | 39 | 0.180 |
Why?
|
| Food | 2 | 2022 | 127 | 0.180 |
Why?
|
| Testosterone | 3 | 2023 | 611 | 0.180 |
Why?
|
| Basal Bodies | 1 | 2021 | 2 | 0.180 |
Why?
|
| Gene Expression Profiling | 5 | 2024 | 1881 | 0.180 |
Why?
|
| Diet Surveys | 2 | 2020 | 101 | 0.180 |
Why?
|
| Infant, Newborn | 2 | 2025 | 8542 | 0.180 |
Why?
|
| Ataxia | 1 | 2022 | 177 | 0.170 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 2554 | 0.170 |
Why?
|
| Trees | 1 | 2000 | 21 | 0.170 |
Why?
|
| Potassium | 1 | 2001 | 275 | 0.170 |
Why?
|
| Coinfection | 1 | 2022 | 189 | 0.170 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2011 | 86 | 0.170 |
Why?
|
| Parenting | 2 | 2021 | 349 | 0.170 |
Why?
|
| Young Adult | 4 | 2024 | 9952 | 0.170 |
Why?
|
| Parents | 3 | 2023 | 1079 | 0.160 |
Why?
|
| Swine | 1 | 2023 | 1180 | 0.160 |
Why?
|
| Cooking | 1 | 2020 | 36 | 0.160 |
Why?
|
| Aged | 8 | 2024 | 21387 | 0.160 |
Why?
|
| Meals | 1 | 2020 | 60 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 1246 | 0.160 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2019 | 288 | 0.160 |
Why?
|
| Disease Susceptibility | 2 | 2018 | 294 | 0.160 |
Why?
|
| Carbon Radioisotopes | 1 | 2009 | 68 | 0.150 |
Why?
|
| Herbicides | 1 | 2009 | 14 | 0.150 |
Why?
|
| Phytochemicals | 1 | 2019 | 9 | 0.150 |
Why?
|
| Genetic Engineering | 1 | 2020 | 164 | 0.150 |
Why?
|
| United States | 4 | 2025 | 11648 | 0.150 |
Why?
|
| Serratia | 1 | 2018 | 1 | 0.150 |
Why?
|
| Serratia Infections | 1 | 2018 | 6 | 0.150 |
Why?
|
| Texas | 2 | 2024 | 3627 | 0.140 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2018 | 32 | 0.140 |
Why?
|
| Life Style | 1 | 2021 | 453 | 0.140 |
Why?
|
| Proteomics | 1 | 2022 | 596 | 0.140 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 1422 | 0.140 |
Why?
|
| Linkage Disequilibrium | 1 | 2019 | 316 | 0.140 |
Why?
|
| Pesticides | 1 | 2018 | 30 | 0.140 |
Why?
|
| RNA Interference | 1 | 2020 | 514 | 0.140 |
Why?
|
| Aspirin | 1 | 2019 | 220 | 0.140 |
Why?
|
| Child, Preschool | 5 | 2025 | 14732 | 0.140 |
Why?
|
| Infant, Premature | 1 | 2023 | 843 | 0.140 |
Why?
|
| Amino Acid Sequence | 3 | 2012 | 2669 | 0.140 |
Why?
|
| Plant Extracts | 2 | 2015 | 135 | 0.140 |
Why?
|
| Gene Expression | 2 | 2022 | 1558 | 0.140 |
Why?
|
| Androgens | 2 | 2023 | 277 | 0.140 |
Why?
|
| Disease Models, Animal | 2 | 2022 | 4680 | 0.140 |
Why?
|
| Feeding Behavior | 2 | 2021 | 721 | 0.140 |
Why?
|
| Environment | 1 | 2018 | 148 | 0.140 |
Why?
|
| Exercise | 1 | 2023 | 858 | 0.130 |
Why?
|
| Seizures | 1 | 2022 | 893 | 0.130 |
Why?
|
| Alphaproteobacteria | 1 | 2016 | 3 | 0.130 |
Why?
|
| Cluster Analysis | 2 | 2016 | 430 | 0.130 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2013 | 351 | 0.130 |
Why?
|
| Ants | 1 | 2016 | 9 | 0.130 |
Why?
|
| Blood Platelets | 1 | 2019 | 320 | 0.130 |
Why?
|
| Multigene Family | 1 | 2017 | 305 | 0.130 |
Why?
|
| Gerbillinae | 2 | 2013 | 55 | 0.130 |
Why?
|
| Models, Animal | 1 | 2018 | 468 | 0.130 |
Why?
|
| Influenza, Human | 1 | 2022 | 699 | 0.120 |
Why?
|
| Patch-Clamp Techniques | 3 | 2001 | 294 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2023 | 916 | 0.120 |
Why?
|
| Glutamate-Ammonia Ligase | 2 | 2016 | 11 | 0.120 |
Why?
|
| Colectomy | 1 | 2016 | 84 | 0.120 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2016 | 141 | 0.120 |
Why?
|
| Nutritive Value | 1 | 2015 | 82 | 0.120 |
Why?
|
| Stereoisomerism | 1 | 2015 | 119 | 0.120 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2014 | 540 | 0.120 |
Why?
|
| Adolescent | 5 | 2024 | 20535 | 0.120 |
Why?
|
| Up-Regulation | 1 | 2017 | 876 | 0.110 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 902 | 0.110 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2014 | 20 | 0.110 |
Why?
|
| Scavenger Receptors, Class B | 2 | 2024 | 12 | 0.110 |
Why?
|
| DNA, Ribosomal | 1 | 2014 | 57 | 0.110 |
Why?
|
| Prospective Studies | 2 | 2023 | 6569 | 0.110 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2014 | 51 | 0.110 |
Why?
|
| Thrombin | 1 | 2014 | 60 | 0.110 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2014 | 261 | 0.110 |
Why?
|
| Genes, Insect | 1 | 2014 | 126 | 0.110 |
Why?
|
| Intestinal Mucosa | 2 | 2024 | 794 | 0.100 |
Why?
|
| Chronic Disease | 1 | 2018 | 1233 | 0.100 |
Why?
|
| Colitis, Ulcerative | 1 | 2016 | 217 | 0.100 |
Why?
|
| Receptors, Androgen | 1 | 2016 | 409 | 0.100 |
Why?
|
| Flavobacteriaceae | 1 | 2013 | 4 | 0.100 |
Why?
|
| Survival Rate | 1 | 2018 | 2186 | 0.100 |
Why?
|
| Drosophila | 1 | 2017 | 823 | 0.100 |
Why?
|
| Seminiferous Tubules | 1 | 2012 | 15 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 2 | 2015 | 1547 | 0.100 |
Why?
|
| Safflower Oil | 1 | 2012 | 1 | 0.100 |
Why?
|
| Arizona | 1 | 2012 | 27 | 0.100 |
Why?
|
| Child | 5 | 2024 | 25761 | 0.100 |
Why?
|
| Polygalacturonase | 1 | 2012 | 3 | 0.100 |
Why?
|
| Pectins | 1 | 2012 | 10 | 0.100 |
Why?
|
| Plant Oils | 1 | 2012 | 34 | 0.090 |
Why?
|
| Cytokines | 1 | 2018 | 1359 | 0.090 |
Why?
|
| RNA Editing | 1 | 2012 | 36 | 0.090 |
Why?
|
| Codon | 1 | 2012 | 98 | 0.090 |
Why?
|
| Carbohydrate Metabolism | 1 | 2012 | 51 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2018 | 1696 | 0.090 |
Why?
|
| Fatty Liver | 1 | 2014 | 211 | 0.090 |
Why?
|
| Genes, Bacterial | 1 | 2012 | 217 | 0.090 |
Why?
|
| Selection, Genetic | 1 | 2012 | 164 | 0.090 |
Why?
|
| Nucleic Acid Conformation | 1 | 2012 | 182 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2013 | 3037 | 0.090 |
Why?
|
| Pilot Projects | 3 | 2021 | 1440 | 0.090 |
Why?
|
| Diet, Protein-Restricted | 1 | 2012 | 82 | 0.090 |
Why?
|
| Metagenomics | 1 | 2012 | 106 | 0.090 |
Why?
|
| Glutamate Synthase | 1 | 2011 | 1 | 0.090 |
Why?
|
| Fetal Development | 1 | 2012 | 131 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2018 | 3409 | 0.090 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2011 | 34 | 0.090 |
Why?
|
| Weight Gain | 1 | 2013 | 381 | 0.090 |
Why?
|
| Inflammation | 1 | 2018 | 1519 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2014 | 1044 | 0.080 |
Why?
|
| Adipose Tissue | 1 | 2013 | 504 | 0.080 |
Why?
|
| Protein Biosynthesis | 2 | 2012 | 584 | 0.080 |
Why?
|
| Chromosome Mapping | 1 | 2012 | 1095 | 0.080 |
Why?
|
| Models, Genetic | 1 | 2012 | 771 | 0.080 |
Why?
|
| Organ Size | 3 | 2016 | 447 | 0.070 |
Why?
|
| Sequence Analysis, RNA | 1 | 2011 | 408 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 4751 | 0.070 |
Why?
|
| Mice, Transgenic | 3 | 2023 | 2443 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 1015 | 0.070 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 2 | 2019 | 111 | 0.060 |
Why?
|
| Feasibility Studies | 2 | 2021 | 820 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 2056 | 0.060 |
Why?
|
| Gene Flow | 1 | 2025 | 15 | 0.060 |
Why?
|
| Bacterial Proteins | 2 | 2016 | 930 | 0.060 |
Why?
|
| Caco-2 Cells | 1 | 2024 | 92 | 0.060 |
Why?
|
| Hemoglobins | 2 | 2023 | 322 | 0.050 |
Why?
|
| CD36 Antigens | 1 | 2024 | 41 | 0.050 |
Why?
|
| Xenobiotics | 1 | 2024 | 28 | 0.050 |
Why?
|
| Ecology | 1 | 2023 | 16 | 0.050 |
Why?
|
| Melanins | 1 | 2023 | 18 | 0.050 |
Why?
|
| Accelerometry | 1 | 2023 | 64 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2016 | 3860 | 0.050 |
Why?
|
| Heat-Shock Response | 1 | 2003 | 37 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2016 | 677 | 0.050 |
Why?
|
| Steroids | 1 | 2024 | 173 | 0.050 |
Why?
|
| Mammals | 1 | 2024 | 272 | 0.050 |
Why?
|
| Tetraethylammonium | 1 | 2001 | 11 | 0.050 |
Why?
|
| Death | 1 | 2022 | 79 | 0.050 |
Why?
|
| Cesium | 1 | 2001 | 11 | 0.050 |
Why?
|
| Geranylgeranyl-Diphosphate Geranylgeranyltransferase | 1 | 2011 | 2 | 0.050 |
Why?
|
| Extracellular Space | 1 | 2001 | 85 | 0.050 |
Why?
|
| Enterobacter | 1 | 2011 | 15 | 0.050 |
Why?
|
| Alkyl and Aryl Transferases | 1 | 2011 | 18 | 0.050 |
Why?
|
| Bioengineering | 1 | 2011 | 15 | 0.040 |
Why?
|
| Membranes | 1 | 2021 | 17 | 0.040 |
Why?
|
| Flagella | 1 | 2021 | 29 | 0.040 |
Why?
|
| Gene Rearrangement | 1 | 2003 | 327 | 0.040 |
Why?
|
| Protons | 1 | 2001 | 98 | 0.040 |
Why?
|
| Proteome | 1 | 2003 | 279 | 0.040 |
Why?
|
| Oxidoreductases | 1 | 2011 | 101 | 0.040 |
Why?
|
| Electrophysiology | 1 | 2001 | 269 | 0.040 |
Why?
|
| Seasons | 1 | 2022 | 327 | 0.040 |
Why?
|
| Biological Transport | 1 | 2001 | 348 | 0.040 |
Why?
|
| DNA, Plant | 1 | 2000 | 11 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2001 | 448 | 0.040 |
Why?
|
| Introduced Species | 1 | 2020 | 26 | 0.040 |
Why?
|
| Vitis | 1 | 2020 | 14 | 0.040 |
Why?
|
| Animal Distribution | 1 | 2020 | 16 | 0.040 |
Why?
|
| Plant Leaves | 1 | 2000 | 55 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2023 | 473 | 0.040 |
Why?
|
| Testis | 2 | 2012 | 422 | 0.040 |
Why?
|
| Ion Channel Gating | 1 | 2000 | 123 | 0.040 |
Why?
|
| Metabolomics | 1 | 2024 | 480 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2022 | 359 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 2001 | 303 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2021 | 356 | 0.040 |
Why?
|
| Parent-Child Relations | 1 | 2021 | 253 | 0.040 |
Why?
|
| Nutritional Status | 1 | 2021 | 294 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2001 | 470 | 0.040 |
Why?
|
| Movement | 1 | 2000 | 168 | 0.040 |
Why?
|
| Hydroxides | 1 | 2008 | 3 | 0.040 |
Why?
|
| Faculty, Medical | 1 | 2022 | 277 | 0.040 |
Why?
|
| Potassium Compounds | 1 | 2008 | 7 | 0.040 |
Why?
|
| Middle Cerebral Artery | 1 | 2019 | 115 | 0.040 |
Why?
|
| Organophosphates | 1 | 2008 | 21 | 0.040 |
Why?
|
| North Carolina | 1 | 2018 | 67 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 1347 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2008 | 252 | 0.030 |
Why?
|
| Ethanol | 1 | 2008 | 162 | 0.030 |
Why?
|
| Ferritins | 1 | 1997 | 109 | 0.030 |
Why?
|
| Type I Secretion Systems | 1 | 2016 | 1 | 0.030 |
Why?
|
| Choristoma | 1 | 1997 | 46 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 285 | 0.030 |
Why?
|
| Nitrogen Fixation | 1 | 2016 | 6 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2019 | 278 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 3678 | 0.030 |
Why?
|
| Erythrocytes | 1 | 1997 | 201 | 0.030 |
Why?
|
| Urease | 1 | 2016 | 74 | 0.030 |
Why?
|
| Pollination | 1 | 2016 | 1 | 0.030 |
Why?
|
| Temporal Lobe | 1 | 1997 | 118 | 0.030 |
Why?
|
| Infliximab | 1 | 2016 | 69 | 0.030 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 1997 | 91 | 0.030 |
Why?
|
| Australia | 1 | 2016 | 185 | 0.030 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2016 | 115 | 0.030 |
Why?
|
| Prevalence | 1 | 2022 | 2658 | 0.030 |
Why?
|
| Cyclosporine | 1 | 2016 | 126 | 0.030 |
Why?
|
| Pregnancy | 2 | 2022 | 7543 | 0.030 |
Why?
|
| Plant Preparations | 1 | 2015 | 15 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2014 | 1044 | 0.030 |
Why?
|
| Cell Line | 1 | 2010 | 2718 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 7097 | 0.030 |
Why?
|
| Plasma | 1 | 2015 | 102 | 0.030 |
Why?
|
| China | 1 | 2015 | 290 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 249 | 0.030 |
Why?
|
| Brain Diseases | 1 | 1997 | 305 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1183 | 0.030 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2014 | 61 | 0.030 |
Why?
|
| Prostatectomy | 1 | 2015 | 358 | 0.030 |
Why?
|
| Venous Thromboembolism | 1 | 2016 | 186 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2016 | 4703 | 0.020 |
Why?
|
| Random Allocation | 1 | 2014 | 430 | 0.020 |
Why?
|
| Coconut Oil | 1 | 2012 | 2 | 0.020 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2012 | 50 | 0.020 |
Why?
|
| Cytochrome P-450 CYP11B2 | 1 | 2011 | 3 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 1284 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2012 | 329 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 323 | 0.020 |
Why?
|
| Spleen | 1 | 2012 | 270 | 0.020 |
Why?
|
| Stroke | 1 | 2019 | 1083 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 3990 | 0.020 |
Why?
|
| Lactation | 1 | 2012 | 198 | 0.020 |
Why?
|
| Triglycerides | 1 | 2014 | 617 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 1997 | 948 | 0.020 |
Why?
|
| Amino Acids | 1 | 2013 | 626 | 0.020 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2012 | 240 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 1991 | 233 | 0.020 |
Why?
|
| Cholesterol | 1 | 2012 | 558 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 2507 | 0.020 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2014 | 419 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2014 | 2674 | 0.020 |
Why?
|
| DNA | 1 | 2014 | 1472 | 0.020 |
Why?
|
| Body Weight | 1 | 2012 | 994 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2013 | 803 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 6440 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 1657 | 0.020 |
Why?
|
| Glioma | 1 | 1991 | 529 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 10933 | 0.010 |
Why?
|
| Anemia, Hypochromic | 1 | 1997 | 7 | 0.010 |
Why?
|
| Aluminum | 1 | 1997 | 14 | 0.010 |
Why?
|
| Vitamin B 12 | 1 | 1997 | 62 | 0.010 |
Why?
|
| Gliosis | 1 | 1997 | 31 | 0.010 |
Why?
|
| Erythropoietin | 1 | 1997 | 107 | 0.010 |
Why?
|
| Amygdala | 1 | 1997 | 82 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1997 | 698 | 0.010 |
Why?
|
| Folic Acid | 1 | 1997 | 288 | 0.010 |
Why?
|
| Iron | 1 | 1997 | 302 | 0.010 |
Why?
|
| Hippocampus | 1 | 1997 | 815 | 0.010 |
Why?
|
| RNA Probes | 1 | 1991 | 30 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1991 | 252 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1991 | 275 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1991 | 319 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1991 | 862 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1991 | 719 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1997 | 5408 | 0.000 |
Why?
|
| Rats | 1 | 1991 | 3608 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 1997 | 12994 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 1991 | 1536 | 0.000 |
Why?
|